Filtered By:
Countries: Turkey Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 16 results found since Jan 2013.
Trace element & amp; vitamin content of Ankaferd hemostat and hepatoprotective effect
Turk J Med Sci. 2021 Nov 13. doi: 10.3906/sag-2109-30. Online ahead of print.ABSTRACT...PMID:34773687 | DOI:10.3906/sag-2109-30
Source: Turkish Journal of Medical Sciences - November 13, 2021 Category: General Medicine Authors: Beg üm Güneş Nazife Yasemin Ardi çoğlu Akişin Mehmet Nejat Akar Source Type: research
High zinc content of Ankaferd hemostat and wound healing effect
Turk J Med Sci. 2021 Jun 27. doi: 10.3906/sag-2105-33. Online ahead of print.ABSTRACT......PMID:34174802 | DOI:10.3906/sag-2105-33
Source: Turkish Journal of Medical Sciences - June 27, 2021 Category: General Medicine Authors: Nazife Yasemin Ardi çoğlu Akişin Mehmet Nejat Akar Source Type: research
Anti-infective and wound-healing pleiotropic actions of Ankaferd hemostat.
Authors: Haznedaroğlu IC, Çelebier M
Abstract
no needed for the letter to the editor.
PMID: 32305048 [PubMed - as supplied by publisher]
Source: Turkish Journal of Medical Sciences - April 21, 2020 Category: General Medicine Tags: Turk J Med Sci Source Type: research
Ankaferd hemostat: from molecules to medicine.
ANKAFERD HEMOSTAT: FROM MOLECULES TO MEDICINE.
Turk J Med Sci. 2020 Apr 14;:
Authors: Çiftçiler R, Haznedaroglu IC
Abstract
Ankaferd hemostat (ABS; Ankaferd blood stopper®, Istanbul, Turkey) is a hemostatic agent having an impact on red blood cell-fibrinogen interactions. The hemostatic effect of ABS depends upon the quick promotion of a protein network, particularly fibrinogen gamma, in relation to the erythrocyte aggregation. The entire physiological process involves ABS-induced formation of the protein network by vital erythrocyte aggregation. Vital erythroid aggregation occurs with the spectrine...
Source: Turkish Journal of Medical Sciences - April 15, 2020 Category: General Medicine Tags: Turk J Med Sci Source Type: research
Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance
Conclusion: Our present study indicated, for the first time, that ABS could act against H. pylori. ABS is clinically used for the management of GI bleeding due to benign and malignant GI lesions. Thus, the possible anti-H. pylori effect of ABS shall expand the therapeutic spectrum of the drug in GI lesions in relation to H. pylori infection such as peptic ulser disease (PUD) and lymphoid tissue (MALT) lymphomagenesis.
PMID: 30761849 [PubMed - in process]
Source: Turkish Journal of Medical Sciences - February 16, 2019 Category: General Medicine Tags: Turk J Med Sci Source Type: research
